Patents by Inventor Scott M. Goldman

Scott M. Goldman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8623094
    Abstract: An implant for deployment in select locations or select tissue for regeneration of tissue is disclosed. The implant comprising collagen and or other bio-resorbable materials, where the implant may also be used for therapy delivery. Additionally, the implant may be “matched” to provide the implant with similar physical and/or chemical properties as the host tissue.
    Type: Grant
    Filed: July 10, 2007
    Date of Patent: January 7, 2014
    Assignee: Kensey Nash BVF Technology LLC
    Inventors: Douglas G Evans, Scott M. Goldman, Russell T. Kronengold
  • Patent number: 8557593
    Abstract: The invention relates to the detection of DHA and EPA. In a particular aspect, the invention relates to methods for detecting DHA and EPA by mass spectrometry.
    Type: Grant
    Filed: September 15, 2011
    Date of Patent: October 15, 2013
    Assignee: Quest Diagnostics Investments Incorporated
    Inventors: Scott M. Goldman, Julie A. Neidich
  • Patent number: 8435306
    Abstract: An implant for deployment in select locations or select tissue for regeneration of tissue is disclosed. The implant includes collagen and or other bio-resorbable materials, where the implant may also be used for therapy delivery.
    Type: Grant
    Filed: November 16, 2010
    Date of Patent: May 7, 2013
    Assignee: Kensey Nash BVF Technology LLC
    Inventors: Douglas G Evans, Scott M. Goldman, Russell T. Kronengold
  • Patent number: 8425619
    Abstract: An implant for deployment in select locations or select tissue for regeneration of tissue is disclosed. The implant includes collagen and or other bio-resorbable materials, where the implant may also be used for therapy delivery.
    Type: Grant
    Filed: November 16, 2010
    Date of Patent: April 23, 2013
    Assignee: Kensey Nash BVF Technology, LLC
    Inventors: Douglas G Evans, Scott M. Goldman, Russell T. Kronengold
  • Patent number: 8419802
    Abstract: An implant for deployment in select locations or select tissue for regeneration of tissue is disclosed. The implant includes collagen and or other bio-resorbable materials, where the implant may also be used for therapy delivery. Additionally, the implant may be “matched” to provide the implant with similar physical and/or chemical properties as the host tissue.
    Type: Grant
    Filed: February 10, 2011
    Date of Patent: April 16, 2013
    Assignee: Kensey Nash BVF Technology, LLC
    Inventors: Douglas G Evans, Scott M. Goldman, Russell T. Kronengold
  • Patent number: 8403996
    Abstract: An implantable device for facilitating the healing of voids in bone, cartilage and soft tissue is disclosed. A preferred embodiment includes a cartilage region comprising a polyelectrolytic complex joined with a subchondral bone region. The cartilage region, of this embodiment, enhances the environment for chondrocytes to grow articular cartilage; while the subchondral bone region enhances the environment for cells which migrate into that region's macrostructure and which differentiate into osteoblasts. A hydrophobic barrier exists between the regions, of this embodiment. In one embodiment, the polyelectrolytic complex transforms to hydrogel, following the implant procedure.
    Type: Grant
    Filed: November 29, 2006
    Date of Patent: March 26, 2013
    Assignee: Kensey Nash Corporation
    Inventors: John H. Brekke, Gino Bradica, Scott M. Goldman
  • Publication number: 20120207808
    Abstract: An implant for deployment in select locations or select tissue for regeneration of tissue is disclosed. The implant includes collagen and or other bio-resorbable materials, where the implant may also be used for therapy delivery. Additionally, the implant may be “matched” to provide the implant with similar physical and/or chemical properties as the host tissue.
    Type: Application
    Filed: February 10, 2011
    Publication date: August 16, 2012
    Inventors: Douglas G. Evans, Scott M. Goldman, Russell T. Kronengold
  • Patent number: 8163032
    Abstract: An implant for deployment in select locations or select tissue for regeneration of tissue is disclosed. The implant includes collagen and or other bio-resorbable materials, where the implant may also be used for therapy delivery. Additionally, the implant may include, or have blended in, an additive, such as an osteoinductive factor, for example biocompatible ceramics and glass.
    Type: Grant
    Filed: February 22, 2011
    Date of Patent: April 24, 2012
    Assignee: Kensey Nash BVF Technology, LLC
    Inventors: Douglas G Evans, Scott M. Goldman, Russell T. Kronengold
  • Publication number: 20120088305
    Abstract: The invention relates to the detection of DHA and EPA. In a particular aspect, the invention relates to methods for detecting DHA and EPA by mass spectrometry.
    Type: Application
    Filed: September 15, 2011
    Publication date: April 12, 2012
    Inventors: Scott M. Goldman, Julie A. Neidich
  • Publication number: 20120046758
    Abstract: An implant for deployment in select locations or select tissue for regeneration of tissue is disclosed. The implant includes collagen and or other bio-resorbable materials, where the implant may also be used for therapy delivery.
    Type: Application
    Filed: November 16, 2010
    Publication date: February 23, 2012
    Inventors: Douglas G. Evans, Scott M. Goldman, Russell T. Kronengold
  • Publication number: 20120029653
    Abstract: An implant for deployment in select locations or select tissue for regeneration of tissue is disclosed. The implant includes collagen and or other bio-resorbable materials, where the implant may also be used for therapy delivery.
    Type: Application
    Filed: November 16, 2010
    Publication date: February 2, 2012
    Inventors: Douglas G. Evans, Scott M. Goldman, Russell T. Kronengold
  • Publication number: 20110306144
    Abstract: The invention relates to the detection of methylmalonic acid (MMA). In a particular aspect, the invention relates to methods for detecting derivatized methylmalonic acid (MMA) by mass spectrometry.
    Type: Application
    Filed: June 8, 2011
    Publication date: December 15, 2011
    Inventors: Scott M. Goldman, Julie A. Neidich, Denise Salazar, Thomas Lynn
  • Patent number: 7963997
    Abstract: An implantable device for facilitating the healing of voids in bone, cartilage and soft tissue is disclosed. A preferred embodiment includes a cartilage region comprising a polyelectrolytic complex joined with a subchondral bone region. The cartilage region, of this embodiment, enhances the environment for chondrocytes to grow articular cartilage; while the subchondral bone region enhances the environment for cells which migrate into that region's macrostructure and which differentiate into osteoblasts. A hydrophobic barrier exists between the regions, of this embodiment. In one embodiment, the polyelectrolytic complex transforms to hydrogel, following the implant procedure.
    Type: Grant
    Filed: April 21, 2004
    Date of Patent: June 21, 2011
    Assignee: Kensey Nash Corporation
    Inventors: John H. Brekke, Gino Bradica, Scott M. Goldman
  • Publication number: 20110144767
    Abstract: An implant for deployment in select locations or select tissue for regeneration of tissue is disclosed. The implant includes collagen and or other bio-resorbable materials, where the implant may also be used for therapy delivery. Additionally, the implant may include, or have blended in, an additive, such as an osteoinductive factor, for example biocompatible ceramics and glass.
    Type: Application
    Filed: February 22, 2011
    Publication date: June 16, 2011
    Inventors: Douglas G. Evans, Scott M. Goldman, Russell T. Kronengold
  • Publication number: 20110112655
    Abstract: An implantable device for facilitating the healing of voids in bone, cartilage and soft tissue is disclosed. A preferred embodiment includes a cartilage region comprising a polyelectrolytic complex joined with a subchondral bone region. The cartilage region, of this embodiment, enhances the environment for chondrocytes to grow articular cartilage; while the subchondral bone region enhances the environment for cells which migrate into that region's macrostructure and which differentiate into osteoblasts. A hydrophobic barrier exists between the regions, of this embodiment. In one embodiment, the polyelectrolytic complex transforms to hydrogel, following the implant procedure.
    Type: Application
    Filed: November 29, 2006
    Publication date: May 12, 2011
    Inventors: John H. Brekke, Gino Bradica, Scott M. Goldman
  • Patent number: 7892291
    Abstract: An implant for deployment in select locations or select tissue for regeneration of tissue is disclosed. The implant includes collagen and or other bio-resorbable materials, where the implant may also be used for therapy delivery. Additionally, the implant may include, or have blended in, an additive, such as an osteoinductive factor, for example biocompatible ceramics and glass.
    Type: Grant
    Filed: October 7, 2008
    Date of Patent: February 22, 2011
    Assignee: Kensey Nash BVF Technology, LLC
    Inventors: Douglas G Evans, Scott M. Goldman, Russell T. Kronengold
  • Patent number: 7887598
    Abstract: An implant for deployment in select locations or select tissue for regeneration of tissue is disclosed. The implant includes collagen and or other bio-resorbable materials, where the implant may also be used for therapy delivery. Additionally, the implant may be “matched” to provide the implant with similar physical and/or chemical properties as the host tissue.
    Type: Grant
    Filed: October 27, 2007
    Date of Patent: February 15, 2011
    Assignee: Kensey Nash BVF Technology, LLC
    Inventors: Douglas G Evans, Scott M. Goldman, Russell T. Kronengold
  • Patent number: 7833278
    Abstract: An implant for deployment in select locations or select tissue for regeneration of tissue is disclosed. The implant includes collagen and or other bio-resorbable materials, where the implant may also be used for therapy delivery.
    Type: Grant
    Filed: October 20, 2008
    Date of Patent: November 16, 2010
    Assignee: Kensey Nash BVF Technology, LLC
    Inventors: Douglas G Evans, Scott M. Goldman, Russell T. Kronengold
  • Patent number: 7776100
    Abstract: An implantable device for facilitating the healing of voids in bone, cartilage and soft tissue is disclosed. A preferred embodiment includes a cartilage region comprising a polyelectrolytic complex joined with a subchondral bone region. The cartilage region, of this embodiment, enhances the environment for chondrocytes to grow articular cartilage; while the subchondral bone region enhances the environment for cells which migrate into that region's macrostructure and which differentiate into osteoblasts. A hydrophobic barrier exists between the regions, of this embodiment. In one embodiment, the polyelectrolytic complex transforms to hydrogel, following the implant procedure.
    Type: Grant
    Filed: September 8, 2004
    Date of Patent: August 17, 2010
    Assignee: Kensey Nash Corporation
    Inventors: John H. Brekke, Gino Bradica, Scott M. Goldman
  • Publication number: 20090110710
    Abstract: An implant for deployment in select locations or select tissue for regeneration of tissue is disclosed. The implant includes collagen and or other bio-resorbable materials, where the implant may also be used for therapy delivery. Additionally, the implant may be “matched” to provide the implant with similar physical and/or chemical properties as the host tissue.
    Type: Application
    Filed: October 27, 2007
    Publication date: April 30, 2009
    Inventors: Douglas G. Evans, Scott M. Goldman, Russell T. Kronengold